7281 related articles for article (PubMed ID: 19886361)
21. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
[TBL] [Abstract][Full Text] [Related]
22. [Identification of biomarkers in serum of early rheumatoid arthritis by proteomic methods].
An Y; Pu H; He SZ; Li ZG
Zhonghua Yi Xue Za Zhi; 2005 May; 85(18):1261-5. PubMed ID: 16029612
[TBL] [Abstract][Full Text] [Related]
23. Protein profiles in sera of patients with malignant cutaneous melanoma.
Ferrari L; Seraglia R; Rossi CR; Bertazzo A; Lise M; Allegri G; Traldi P
Rapid Commun Mass Spectrom; 2000; 14(13):1149-54. PubMed ID: 10867691
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
25. Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer.
Han M; Dai J; Zhang Y; Lin Q; Jiang M; Xu X; Liu Q; Jia J
Oncol Rep; 2012 Dec; 28(6):2233-8. PubMed ID: 22992788
[TBL] [Abstract][Full Text] [Related]
26. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
[TBL] [Abstract][Full Text] [Related]
27. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A; Banoub J
Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
[TBL] [Abstract][Full Text] [Related]
29. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.
Wu FX; Wang Q; Zhang ZM; Huang S; Yuan WP; Liu JY; Ban KC; Zhao YN
Cancer Lett; 2009 Jul; 279(2):163-70. PubMed ID: 19268439
[TBL] [Abstract][Full Text] [Related]
30. Serum peptidome patterns of human systemic lupus erythematosus based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
Dai Y; Hu C; Wang L; Huang Y; Zhang L; Xiao X; Tan Y
Scand J Rheumatol; 2010 May; 39(3):240-6. PubMed ID: 20166849
[TBL] [Abstract][Full Text] [Related]
31. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
[TBL] [Abstract][Full Text] [Related]
32. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
[TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
34. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
35. Serum proteomic profiling analysis of chronic arsenic exposure by using SELDI-TOF-MS technology.
Zhao L; Gao Y; Yang Y; Wei Y; Li Y; Feng H; Wei W; Ding Y; Sun D
Toxicol Lett; 2010 Jun; 195(2-3):155-60. PubMed ID: 20362649
[TBL] [Abstract][Full Text] [Related]
36. Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: association to tumor derived alpha-N-acetylgalactosaminidase activity.
Greco M; Mitri MD; Chiriacò F; Leo G; Brienza E; Maffia M
Cancer Lett; 2009 Oct; 283(2):222-9. PubMed ID: 19394758
[TBL] [Abstract][Full Text] [Related]
37. Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma.
Brouwers FM; Petricoin EF; Ksinantova L; Breza J; Rajapakse V; Ross S; Johann D; Mannelli M; Shulkin BL; Kvetnansky R; Eisenhofer G; Walther MM; Hitt BA; Conrads TP; Veenstra TD; Mannion DP; Wall MR; Wolfe GM; Fusaro VA; Liotta LA; Pacak K
Endocr Relat Cancer; 2005 Jun; 12(2):263-72. PubMed ID: 15947101
[TBL] [Abstract][Full Text] [Related]
38. Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry.
Gaines PJ; Powell TD; Walmsley SJ; Estredge KL; Wisnewski N; Stinchcomb DT; Withrow SJ; Lana SE
Am J Vet Res; 2007 Apr; 68(4):405-10. PubMed ID: 17397297
[TBL] [Abstract][Full Text] [Related]
39. Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
Mosley K; Tam FW; Edwards RJ; Crozier J; Pusey CD; Lightstone L
Rheumatology (Oxford); 2006 Dec; 45(12):1497-504. PubMed ID: 17046860
[TBL] [Abstract][Full Text] [Related]
40. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) in orthodontic treatment: first pilot study.
Ciavarella D; Mastrovincenzo M; D'Onofrio V; Chimenti C; Parziale V; Barbato E; Lo Muzio L
Prog Orthod; 2011 Nov; 12(2):126-31. PubMed ID: 22074837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
